Ocumetics Technology Corp. announced that it has appointed Mr. Dean Burns as Ocumetics' President and CEO. Mr. Burns will also join the Ocumetics board of directors.

Mr. Burns was previously a consultant of the Corporation, assisting with the Corporation's regulatory and marketing endeavours. Further to the announcement of Dr. Mark Lee's resignation effective June 30, 2023, Dr. Lee stepped down as President and CEO on June 12, 2023. Mr. Burns is recently retired from Alcon Vision, where he was a Senior Director of Cataract Instrumentation and Advanced Consumable Technology, a USD 750 million business of Alcon.

At Alcon, Mr. Burns managed technologies in four therapeutic categories: Cataract, Refractive, Retinal and Pharmaceutical. Mr. Burns' 27-year career with Alcon brings a diverse healthcare experience to Ocumetics. His experience included developing plans to commercialize acquired technologies and line extension of existing products.

He also has skills and experience in marketing and sales management, manufacturing, comprehensive understanding of the regulatory process for devices, Key Opinion Leader management, and surgeon clinical training. Mr. Burns' accomplishments include over 15 FDA product approvals and five business development and licensing acquisition projects totaling USD 2.3 billion.